Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Portage Biotech Inc PRTG

Healthcare Biotechnology
Portage Biotech Inc. is a clinical-stage immuno-oncology company. The Company is engaged in advancing therapies to improve long-term treatment response, and quality of life in patients with cancers. The Company’s access to technologies coupled with biological mechanisms enables the identification of clinical therapies and product development strategies, which accelerate these medicines through... see more

Recent & Breaking News (NDAQ:PRTG)

Portage Biotech Provides Research and Development Update and Announces NASDAQ Listing Approval

Newsfile February 11, 2021

CEO Spotlight: Portage Biotech CEO Dr. Ian Walters Talks Asset Pipeline, Uplist, and Strategic Initiatives in a $20 Billion Sector

Newsfile December 1, 2020

Portage Announces Filing of Q1 Interim Financial Statements; Correction to SalvaRX Loan Note Settlement Announcement

Newsfile October 16, 2020

Portage Issues Common Shares and Warrants in Settlement of SalvaRx Loan Note Obligations

Newsfile October 13, 2020

Portage Announces Reliance on Temporary Regulatory Relief for Filing Q1 Interim Financial Statements

Newsfile August 28, 2020

Portage Announces Filing of Annual Financial Statements

Newsfile August 24, 2020

Portage Announces Reliance on Temporary Regulatory Relief for Filing Annual Financial Statements

Newsfile July 28, 2020

Portage Announces Results of Annual Meeting; Private Placement Update; Corporate Update

PR Newswire June 26, 2020

Portage Raises More Than US$6.7 Million Through Non-Brokered Private Placement; Temporary Symbol Change on OTC Markets

PR Newswire June 16, 2020

CSE Bulletin: Consolidation - Portage Biotech Inc. (PBT.U)

Newsfile June 3, 2020

Portage Announces Share Consolidation (Reverse Split) Effective Date

PR Newswire June 3, 2020

Portage Announces Non-Brokered Private Placement

PR Newswire May 25, 2020

Portage is pleased to announce the appointment of Allan L. Shaw as CFO

PR Newswire May 12, 2020

Portage Makes Additional Investment in Stimunity S.A.S, a Paris-Based Cancer Immunotherapy Company.

PR Newswire May 11, 2020

Portage makes an additional investment in Saugatuck therapeutics after achieving proof of concept

PR Newswire May 5, 2020

CSE Bulletin: Reinstatement - Portage Biotech Inc. (PBT.U)

Newsfile April 16, 2020

IIROC Trade Resumption - PBT.U

Canada NewsWire April 16, 2020

Portage Announces Cease Trade Order Revoked; Update on Impact of COVID-19 on Operations

Canada NewsWire April 16, 2020

Portage provides update on portfolio company, Intensity Therapeutics, Inc.

PR Newswire April 15, 2020

Portage Files Business Acquisition Report

Canada NewsWire April 6, 2020